Stockreport

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting [Yahoo! Finance]

Ocugen, Inc.  (OCGN) 
PDF discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will present on its innovative modifier gene t [Read more]